How are pharmaceutical manufacturers using hub models to maximize brand access and adherence?
No longer limited to injectable specialty products, brand teams are challenged with many issues that jeopardize patient access to higher-cost traditional drugs, such as increased out-of-pocket costs and patient confusion related to complex dosing or administration protocols. These can impede therapy initiation and adherence over time.
Enter hub models. Hub models provide a single point of entry and streamline the patient and healthcare provider experience with services such as benefit verification; navigating prior authorization requirements with payers; arranging delivery of the drug (to site of care or to the patient’s home); nursing services; and providing follow-up care management.
By removing financial, clinical and administrative obstacles with a unified hub model approach, brand teams benefit from:
- A digital platform to connect patient touchpoints
- Consistent messaging
- Critical data to monitor patient behavior trends
- Containment of costs with unified vendor management
- Speed to therapy
- Increased adherence
- Less prescription abandonment
Register to access this whitepaper using the link below.
|
